Introduction Initiating and retaining pregnant women on antiretroviral therapy (ART) to prevent mother-to-child HIV transmission (PMTCT) remains a major challenge facing African HIV programs, partic
Whether flow cytometry results were obtained at current study visit (Maternal Flow Cytometry CRF) Study Description Describes the characteristics of HIV-infected pregnant women and their HIV-exposed i
Prophylaxis or treatment for TB taken by the mother since last study visit or ever taken (Maternal Medications CRF) Study Description Describes the characteristics of HIV-infected pregnant women and t
